Literature DB >> 3003953

Urokinase antigen in plasma of patients with liver cirrhosis and hepatoma.

J C Kirchheimer, K Huber, P Polterauer, B R Binder.   

Abstract

Plasma urokinase antigen levels were studied in 78 patients suffering from liver diseases. Blood was drawn before any specific medication was initiated. Impairment of liver function was comparable in all patients. In both groups of cirrhotic liver disease (alcoholic and non-alcoholic), normal levels of plasma urokinase antigen were found as compared to age-matched control groups. In both groups of patients with hepatomas (with or without a history of liver cirrhosis), however, significantly increased plasma urokinase antigen levels could be determined. These data indicate that an increase in plasma urokinase antigen might rather relate to malignant growth in liver disease than to impaired liver function.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3003953

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  3 in total

1.  Distribution of plasminogen activator inhibitor in normal liver, cirrhotic liver, and liver with metastases.

Authors:  P Fitch; B Bennett; N A Booth; A Croll; S W Ewen
Journal:  J Clin Pathol       Date:  1994-03       Impact factor: 3.411

2.  Elevated urokinase-type plasminogen activator plasma levels are associated with deterioration of liver function but not with hepatocellular carcinoma.

Authors:  S Sato; T Higashi; S Ouguchi; N Hino; T Tsuji
Journal:  J Gastroenterol       Date:  1994-12       Impact factor: 7.527

3.  Clinical evaluation of tissue plasminogen activator (t-PA) levels in patients with liver diseases.

Authors:  K Okabe; I Kato; S Sato; T Kashiwabara; S Furuta; H Sato; K Tanikawa; R Kumashiro; M Kanayama
Journal:  Gastroenterol Jpn       Date:  1992-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.